- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Leucine-rich alpha-2-glycoprotein 1 (LRG1) is a secreted glycoprotein that plays a key role in angiogenesis, vascular remodeling, and inflammatory signaling. LRG1 antibody is widely used to study this proteinâs involvement in modulating endothelial cell behavior and promoting new blood vessel formation under both physiological and pathological conditions. Originally identified as a serum protein, LRG1 has since been recognized as an important regulator of vascular biology and tissue remodeling processes.
LRG1 antibody, also known as Leucine-rich alpha-2-glycoprotein 1 antibody or LRG-1 antibody in the literature, enables detection of this protein in pathways associated with angiogenesis and immune-related signaling. LRG1 functions by interacting with components of the transforming growth factor beta (TGF-beta) signaling pathway, influencing endothelial cell proliferation, migration, and differentiation. Through this mechanism, it contributes to the regulation of blood vessel formation and stability, particularly in response to injury or inflammation.
Functionally, LRG1 promotes angiogenic switching by modulating TGF-beta signaling toward a pro-angiogenic phenotype. This activity is critical in processes such as wound healing and tissue regeneration, but it is also implicated in disease states including cancer, diabetic retinopathy, and chronic inflammatory conditions. Elevated LRG1 expression has been associated with abnormal vascular growth and increased permeability, highlighting its importance as a marker of pathological angiogenesis. LRG1 antibody provides a valuable tool for investigating these mechanisms in both normal and disease contexts.
Expression of LRG1 is observed in a range of cell types, including endothelial cells, hepatocytes, and immune cells, with secretion into the extracellular environment and circulation. As a secreted protein, LRG1 can act in a paracrine manner to influence neighboring cells within the tissue microenvironment. This extracellular distribution allows it to participate in signaling networks that coordinate vascular remodeling and inflammatory responses. LRG1 antibody is therefore useful for studying both tissue localization and secreted protein dynamics.
Subcellularly, LRG1 is synthesized in the endoplasmic reticulum and secreted through the classical secretory pathway, resulting in extracellular localization. Its leucine-rich repeat structure facilitates protein-protein interactions that are essential for its signaling functions. This structural feature contributes to its ability to modulate receptor signaling pathways and influence cellular responses to environmental cues.
This LRG1 antibody is supported by protein microarray specificity validation, demonstrating selective binding to LRG1 among a large panel of human proteins. Western blot and immunohistochemistry data further support detection of LRG1 in relevant biological samples. Together, these validation approaches provide confidence in specificity and performance, making this antibody a useful reagent for studies of angiogenesis, vascular biology, and inflammatory signaling.
This antibody is part of a broader antibody panel offered by NSJ Bioreagents.
Optimal dilution of the LRG1 Antibody / Angiogenesis Regulation Marker should be determined by the researcher.
A portion of amino acids 30-180 was used as the immunogen for the LRG1 antibody.
Aliquot the LRG1 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
LRG1 antibody, Leucine-rich alpha-2-glycoprotein 1 antibody, LRG-1 antibody, Serum leucine-rich glycoprotein antibody, LRG1 protein antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.